The effect of magnolol on the toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced acute lung injury in mice
The effect of magnolol on the toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced acute lung injury in mice
复制标题
厚朴酚对脂多糖所致小鼠急性肺损伤中Toll样受体4/核因子κB信号通路的影响
DOI:
10.1016/j.ejphar.2012.05.038
复制
发表时间:
2012-08-15
影响因子:
5
通讯作者:
Yang Zhengtao
中科院分区:
文献类型:
--
作者:
Fu Yunhe;Liu Bo;Yang Zhengtao
Magnolol, a hydroxylated biphenyl compound isolated from Magnolia officinalis has been reported to have anti-inflammatory properties. The purpose of this study was to evaluate the effect of magnolol on acute lung injury induced by lipopolysaccharide in mice. Male BALB/c mice were pretreated with dexamethasone or magnolol 1 h before intranasal instillation of lipopolysaccharide (LPS). 7 h after LPS administration, the myeloperoxidase in lung tissues, lung wet/dry weight ratio and inflammatory cells in the bronchoalveolar lavage fluid were determined. The levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and interleukin-1 beta (IL-1 beta) in the bronchoalveolar lavage fluid were measured by enzyme-linked immunosorbent assay (ELISA). The extent of phosphorylation of nuclear factor of inhibitory kappa B alpha (I kappa B-alpha), nuclear factor kappa-B (NF-kappa B) p65 and the expression of Toll-like receptor-4 (TLR4) were detected by western blot. The results showed that magnolol markedly attenuated the histological alterations in the lung; reduced the number of total cells, neutrophils, and macrophages in the bronchoalveolar lavage fluid; decreased the wet/dry weight ratio of lungs in the bronchoalveolar lavage fluid; down-regulated the level of pro-inflammatory mediators, including TNF-alpha, IL-1 beta and IL-6; inhibited the phosphorylation of I kappa B-alpha, NF-kappa B p65 and the expression of TLR4, caused by LPS. Taken together, our results suggest that anti-inflammatory effects of magnolol against the LPS-induced acute lung injury may be due to its ability of inhibition TLR4 mediated NF-kappa B signaling pathways. Magnolol may be a promising potential therapeutic reagent for acute lung injury treatment. (C) 2012 Elsevier B.V. All rights reserved.